Primary mucinous epithelial ovarian carcinoma in a patient with ankylosing spondylitis treated with infiiximab: Case report Infliksimab ile tedavi edilen ankilozan spondilitli bir hastada primer müsinöz epitelyal over karsinomu
Turkiye Klinikleri Journal of Medical Sciences, cilt.33, sa.1, ss.238-240, 2013 (SCI-Expanded)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 33 Sayı: 1
- Basım Tarihi: 2013
- Doi Numarası: 10.5336/medsci.2011-23682
- Dergi Adı: Turkiye Klinikleri Journal of Medical Sciences
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.238-240
- Anahtar Kelimeler: Ankylosing, Infliximab, Ovarian neoplasms, Spondylitis, Tumor necrosis factor alpha (36-68)
- Akdeniz Üniversitesi Adresli: Evet
Özet
Ankylosing spondylitis (AS), the prototype of spondyloarthritis is a chronic inflammatory rheumatic disease with a prevalence of 0.5-1.9% among all types of spondyloarthritis. Inhibition of the proinflammatory cytokine tumour necrosis factor (TNF)-α has demonstrated efficacy in patients with active AS. However, de novo malignancies have been reported in some patients undergoing this therapy representing a major concern. Here, we reported a case with AS who was diagnosed with carcinoma of ovary after receiving therapy with infliximab. Copyright © 2013 by Türkiye Klinikleri.